Japan ready to offer trial Ebola drug

2014-08-25 07:44
File: AFP

File: AFP

Multimedia   ·   User Galleries   ·   News in Pictures Send us your pictures  ·  Send us your stories

Tokyo - Tokyo stands ready to offer an experimental drug developed by a Japanese company to help stem the global tide of the deadly Ebola virus, the top government spokesperson said on Monday.

"Our country is prepared to provide the yet-to-be approved drug in co-operation with the manufacturer if the WHO requests," Chief Cabinet Secretary Yoshihide Suga.

The World Health Organisation (WHO) has been discussing the use of unapproved drugs as a way of getting a handle on an outbreak in Africa that has already cost more than 1 400 lives, with thousands more people infected.

There is currently no available cure or vaccine for Ebola, and the WHO has declared the latest outbreak a global public health emergency.

Several drugs are under development.

Ethical debate

The use of an experimental drug called ZMapp on two Americans and a Spanish priest infected with the virus while working in Africa has opened up an intense ethical debate.

The drug, which is in very short supply, has reportedly shown promising results in the two Americans, although the priest died.

US company Mapp Bioparmaceutical which makes the drug said this month it had sent all its available supplies to west Africa.

The WHO earlier said a panel of medical experts had determined it is "ethical" to provide experimental treatments.

Healthcare fields

Suga said on Monday: "Even before the WHO reaches a conclusion, we are ready to respond to individual requests [from medical workers] under certain conditions if it is an urgent case."

The medication Suga was referring to is Avigan, a drug in tablet form that was approved as an anti-influenza drug in Japan in March and is currently in clinical tests in the United States.

Its developer Fujifilm Holdings said it had received inquiries from abroad but declined to say how many and from which countries.

The company, which has diversified into healthcare fields, has "no problem" over the amount of stockpiles, according to spokesman Takao Aoki.

"We have sufficient supplies for more than 20 000 people," he said.

Read more on:    who  |  us  |  japan  |  ebola  |  health

Join the conversation!

24.com encourages commentary submitted via MyNews24. Contributions of 200 words or more will be considered for publication.

We reserve editorial discretion to decide what will be published.
Read our comments policy for guidelines on contributions.

24.com publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
Comments have been closed for this article.

Inside News24


Book flights

Compare, Book, Fly

Traffic Alerts
There are new stories on the homepage. Click here to see them.


Create Profile

Creating your profile will enable you to submit photos and stories to get published on News24.

Please provide a username for your profile page:

This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire 24.com network.


Location Settings

News24 allows you to edit the display of certain components based on a location. If you wish to personalise the page based on your preferences, please select a location for each component and click "Submit" in order for the changes to take affect.

Facebook Sign-In

Hi News addict,

Join the News24 Community to be involved in breaking the news.

Log in with Facebook to comment and personalise news, weather and listings.